Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 2/2015

01-02-2015 | Letter to the Editor

Extensive toxic epidermal necrolysis following brentuximab vedotin administration

Authors: Maria Ilaria Del Principe, Giuseppe Sconocchia, Francesco Buccisano, Mariagiovanna Cefalo, Ambra Di Veroli, Giovanna De Santis, Daniela Nasso, Luca Maurillo, Lucia Anemona, Massimiliano Postorino, Giovanni Del Poeta, Sergio Amadori, Adriano Venditti

Published in: Annals of Hematology | Issue 2/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 263:1281–5PubMedCrossRef
2.
Gravante G, Esposito G, Marianetti M, Delogu D, Montone A, Sconocchia G (2006) Toxic epidermal necrolysis in patients with malignancies. Ann Oncol 17:1601–2PubMedCrossRef
3.
Mockenhaupt M (2011) The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 7:803–15PubMedCrossRef
4.
Tamiolakis D, Papadopoulos N, Venizelos J, Lambropoulou M, Tsikouras P, Koutsougeras G, Bolioti S, Tsiapali M, Menegaki M, Kouskoukis C (2005) NCL-CD30 Staining of epithelial cells in the basal germinative layer of the epidermis and epithelial buds during foetal skin development. Clin Exp Med 5:184–9PubMedCrossRef
5.
Baldo BA (2013) Adverse events to monoclonal antibodies used for cancer therapy. Focus on hypersensitivity responses. OncoImmunology 2: e26333
6.
Wei CY, Ko TM, Shen CY, Chen YT (2012) A recent update of pharmacogenomics in drug-induced severe skin reactions. Drug Metab Pharmacokinet 27:132–41PubMedCrossRef
Metadata
Title
Extensive toxic epidermal necrolysis following brentuximab vedotin administration
Authors
Maria Ilaria Del Principe
Giuseppe Sconocchia
Francesco Buccisano
Mariagiovanna Cefalo
Ambra Di Veroli
Giovanna De Santis
Daniela Nasso
Luca Maurillo
Lucia Anemona
Massimiliano Postorino
Giovanni Del Poeta
Sergio Amadori
Adriano Venditti
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 2/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2148-3

Other articles of this Issue 2/2015

Annals of Hematology 2/2015 Go to the issue

Letter to the Editor

Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphoma

Original Article

Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients

Original Article

Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation

Original Article

Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia

Letter to the Editor

Fulminant thrombotic thrombocytopenic purpura (TTP): association with amphetamine consumption?

Original Article

Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits